全文获取类型
收费全文 | 104465篇 |
免费 | 8850篇 |
国内免费 | 6097篇 |
专业分类
耳鼻咽喉 | 1112篇 |
儿科学 | 1542篇 |
妇产科学 | 2304篇 |
基础医学 | 12381篇 |
口腔科学 | 1949篇 |
临床医学 | 14001篇 |
内科学 | 16577篇 |
皮肤病学 | 894篇 |
神经病学 | 5663篇 |
特种医学 | 3529篇 |
外国民族医学 | 42篇 |
外科学 | 11233篇 |
综合类 | 14791篇 |
现状与发展 | 23篇 |
一般理论 | 20篇 |
预防医学 | 6115篇 |
眼科学 | 2864篇 |
药学 | 10696篇 |
56篇 | |
中国医学 | 4821篇 |
肿瘤学 | 8799篇 |
出版年
2024年 | 277篇 |
2023年 | 1499篇 |
2022年 | 3795篇 |
2021年 | 4935篇 |
2020年 | 3511篇 |
2019年 | 3225篇 |
2018年 | 3543篇 |
2017年 | 2923篇 |
2016年 | 2842篇 |
2015年 | 4407篇 |
2014年 | 5616篇 |
2013年 | 5006篇 |
2012年 | 7521篇 |
2011年 | 8264篇 |
2010年 | 4976篇 |
2009年 | 3815篇 |
2008年 | 5268篇 |
2007年 | 5524篇 |
2006年 | 5404篇 |
2005年 | 5698篇 |
2004年 | 3830篇 |
2003年 | 3398篇 |
2002年 | 3005篇 |
2001年 | 2440篇 |
2000年 | 2650篇 |
1999年 | 2704篇 |
1998年 | 1578篇 |
1997年 | 1481篇 |
1996年 | 1308篇 |
1995年 | 1161篇 |
1994年 | 982篇 |
1993年 | 635篇 |
1992年 | 998篇 |
1991年 | 805篇 |
1990年 | 684篇 |
1989年 | 600篇 |
1988年 | 593篇 |
1987年 | 529篇 |
1986年 | 420篇 |
1985年 | 330篇 |
1984年 | 208篇 |
1983年 | 159篇 |
1982年 | 85篇 |
1981年 | 98篇 |
1980年 | 83篇 |
1979年 | 115篇 |
1978年 | 54篇 |
1977年 | 56篇 |
1975年 | 44篇 |
1974年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
L.‐Q. Zheng X.‐C. Han Y. Huang H.‐W. Li X.‐D. Niu J. Li 《Clinical and experimental dermatology》2015,40(3):293-297
Porocarcinoma is an unusual, locally aggressive and potentially fatal neoplasm. Several cutaneous malignancies have been described in association with porocarcinoma, including squamous cell carcinoma, basal cell carcinoma and tricholemmal carcinoma. Previous reports have indicated that the occurrence of malignant tumours in combination with porocarcinoma is extremely rare, in particular with regard to Bowen disease (BD). We report an uncommon case of porocarcinoma occurring synchronously in a single BD lesion in a 63‐year‐old woman with multiple BD lesions. The clinical and histological findings confirmed this diagnosis. 相似文献
12.
Gui-Qi Zhu Ke-Qing Shi Sha Huang Gui-Qian Huang Yi-Qian Lin Zhi-Rui Zhou Martin Braddock Yong-Ping Chen Ming-Hua Zheng 《Medicine》2015,94(11)
Major ursodeoxycholic acid (UDCA)-based therapies for primary biliary cirrhosis (PBC) include UDCA only, or combined with either methotrexate (MTX), corticosteroids (COT), colchicine (COC), or bezafibrate (BEF). As the optimum treatment regimen is unclear and warrants exploration, we aimed to compare these therapies in terms of patient mortality or liver transplantation (MOLT) and adverse events (AE).PubMed, the Cochrane Library, and Scopus were searched for randomized controlled trials up to August 31, 2014. We estimated the hazard ratios (HRs) for MOLT and odds ratios (ORs) for AE. A sensitivity analysis based on the dose of UDCA was also executed.Thirty-one eligible articles were included. Compared with COT plus UDCA, UDCA (HR 0.38, 95% confidence interval [CI] 0.09–1.39), BEF plus UDCA (HR 0.29, 95% CI 0.02–4.83), COC plus UDCA (HR 0.39, 95% CI 0.07–2.25), MTX plus UDCA (HR 0.28, 95% CI 0.05–1.63), or OBS (HR 0.49, 95% CI 0.11–2.01) all provided an increased risk of MOLT. With respect to drug AE profile, although not differing appreciably, BEF plus UDCA was associated with more AEs compared with UDCA (OR 3.16, 95% CI 0.59–20.67), COT plus UDCA (OR 2.27, 95% CI 0.15–33.36), COC plus UDCA (OR 1.00, 95% CI 0.09–12.16), MTX plus UDCA (OR 2.03, 95% CI 0.23–17.82), or OBS (OR 3.00, 95% CI 0.53–20.75). The results of sensitivity analyses were highly consistent with previous analyses.COT plus UDCA was the optimal UDCA-based regimen for both MOLT and AEs. BEF plus UDCA was most likely to cause AEs, whereas monotherapy with UDCA and coadministriation of COT plus UDCA appeared to be associated with the fewest AEs for PBC treatment. 相似文献
13.
Shengxuan Cao Chen Wang Xin Ma Xu Wang Jiazhang Huang Chao Zhang Li Chen Xiang Geng Kan Wang 《Journal of orthopaedic research》2019,37(8):1860-1867
Patients with mechanic ankle instability experience increased tibiotalar and subtalar joint laxity. However, in vivo joint kinematics in functional ankle instability (FAI) patients and lateral ankle sprain (LAS) copers, especially during dynamic activities, are poorly understood. Ten FAI patients, 10 LAS copers, and 10 healthy controls were included in this study. A dual fluoroscopic imaging system was used to analyze the tibiotalar and subtalar joint kinematics during stair descent. Five key poses of stair descent were analyzed. Kinematic data from six degrees of freedom were calculated utilizing a solid modeling software. The range of motion and joint positions in each degree of freedom were compared among the three groups. The tibiotalar joints of FAI patients and LAS copers were significantly more inverted than those of healthy controls during the foot strike (p = 0.016, = 0.264). The subtalar joints of FAI patients were significantly more anteriorly translated (pose 2, p = 0.003, = 0.352; pose 3, p < 0.001, = 0.454; pose 4, p = 0.004, = 0.334), inverted (pose 4, p = 0.027, = 0.234; pose 5,p = 0.034, = 0.221), and externally rotated (pose 4, p = 0.037, = 0.217; pose 5; p = 0.004, = 0.331) than those of healthy controls during the mid‐stance and the heel off. The FAI patients showed excessive tibiotalar inversion and subtalar joint hypermobility during stair descent. Meanwhile, the LAS copers maintained subtalar joint stability, and only showed excessive tibiotalar inversion in foot strike. These data provide insight into the mechanisms behind the development of FAI after initial LAS. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1860–1867, 2019 相似文献
14.
15.
16.
17.
骨碎补是历代临床常用中药,具有疗伤止痛、补肾强骨、消风祛斑等功效。其主要含黄酮、苯丙素、三萜、酚酸及其苷等类化学成分,现代研究表明骨碎补具有抗骨质疏松、促进骨折愈合、促软骨再生、护牙健齿、保护肾功能、抗炎、防治中毒性耳聋、降血脂等多种生物活性,开发前景广阔。本文对近年来骨碎补的化学成分、药理作用及临床应用研究进行综述,以期为骨碎补的进一步深入系统的研究和开发利用提供依据。 相似文献
18.
19.
20.